Ethics and equity in rare disease research and healthcare

Per Med. 2021 Jul;18(4):407-416. doi: 10.2217/pme-2020-0144. Epub 2021 Jun 4.

Abstract

Rapid advances in next-generation sequencing technology, particularly whole exome sequencing and whole genome sequencing, have greatly affected our understanding of genetic variation underlying rare genetic diseases. Herein, we describe ethical principles of guiding consent and sharing of genomics research data. We also discuss ethical dilemmas in rare diseases research and patient recruitment policies and address bioethical and societal aspects influencing the ethical framework for genetic testing. Moreover, we focus on addressing ethical issues surrounding research in low- and middle-income countries. Overall, this perspective aims to address key aspects and issues for building proper ethical frameworks, when conducting research involving genomics data with a particular emphasis on rare diseases and genetics testing.

Keywords: ELSI; LMICs; bioethics; ethical frameworks; genetics testing; genomics; patient engagement; patient recruitment; public health; rare diseases.

MeSH terms

  • Delivery of Health Care
  • Genomics*
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Rare Diseases* / genetics